Jaringan Laboratorium Medis

Vol. 3 No. 1 (2021): May 2021
Original Articles

Description of The Chemiluminescence Immunoassay (ChLIA) Method of HIV Screening Test on The Donor's Blood

PDF
  • Tsuraya Nabilah Hasna,
  • Fransisca Romana Sri Supadmi
Tsuraya Nabilah Hasna
Universitas Jenderal Achmad Yani Yogyakarta
Fransisca Romana Sri Supadmi
Universitas Jenderal Achmad Yani Yogyakarta

Published 2021-05-01

Keywords

  • HIV Testing,
  • ChLIA,
  • HIV Testing Resul,
  • Characteristic

Copyright (c) 2021 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Description of The Chemiluminescence Immunoassay (ChLIA) Method of HIV Screening Test on The Donor’s Blood. (2021). Jaringan Laboratorium Medis, 3(1), 1-5. https://doi.org/10.31983/jlm.v3i1.7910

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Human Immunodeficiency Virus (HIV) is one of the transmitted infection through blood transfusion. Chemiluminescence immunoassay for HIV testing is performed to ensure the safety and quality of blood product that released. Purpose of the study to identify the result of Chemiluminescence Immunoassay methode for HIV testing to blood donor’s characteristic based on gender, age, blood group, HIV titer, and donation location. The design of this research is descriptive retrospective. There is 11 (0,8%) reactive blood bag and 1.289 (99,2%) blood bag non reactive to HIV, reactive blood bag based of gender is 8 (72,7%) blood bag from male donors and 3 (27,3%) blood bag from female donors. Based on donors age, mostly reactive result are from 41-70 years old is 4 (36,4%) donors, and the fewest is from < (under) 19 years old is 1 (9,1%) donors. The majority based on blood group is B Rh+ is 4 (36,4%) donors. The majority based on HIV titer is low titer, 1,0-2,0 is 7 (63,6%) donors. Based on donation location, mostly from mobile unit (MU) is 8 (72,7%) donors over 11 donors with HIV reactive. Conclusion of this study is donors gender, donors age, and donation location had a significant influence on reactive result of HIV testing.

PDF

Downloads

Download data is not yet available.

References

  1. Almirah, G., Mumpuni, N., & Supadmi, F. R. S. (2020). Distribution of Blood Components Thrombocyte Concentrate (TC). Jaringan Laboratorium Medis, 02(02), 75–81.
  2. HIV.gov. (2020). What Are HIV and AIDS? (cited 24 Maret 2020) https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and- aids (cited 15 January 2020)
  3. Victoryplusaids. (2019). Jumlah Kasus HIV AIDS DIY Tahun 1993 s.d. Triwulan III Tahun 2019. [cited 15 January 2020] http://www.victoryplusaids.org/
  4. Sands, A. (2015). Annex 7. Diagnostics for HIV diagnosis. World Health Organization.
  5. Peraturan Menteri Kesehatan Nomor 91 Tahun 2015 tentang Standar Pelayanan Darah, Pub. L. No. 91. (2015).
  6. Khoodijah, N. M., dan Qomariyah, N. (2019). Perbedaan Derajat Aglutinasi Pemeriksaan Golongan Darah Metode Cell Grouping Berdasarkan Tingkat Konsentrasi Suspensi Sel. Jaringan Laboratorium Medis, 1(1), 27–33. https://doi.org/10.31983/jlm.v1i1.5181.
  7. Muniarsih, Y. (2020). Profil Hepatitis B pada Pendonor Remaja Hepatitis. Jaringan Laboratorium Medis, 02(01), 27–31.
  8. Ruwiyanti, E. (2020). Profil Hasil Pemeriksaan Crossmatching Incompatible pada Pasien dengan Metode Gel Test. Jaringan Laboratorium Medis, 02(01), 42–45
  9. Triatmojo, B. (2020). Gambaran Hasil Pemeriksaan HIV pada Darah Donor. Jaringan Laboratorium Medis, 02(01), 46–50.
  10. Wibowo, A., & Priyatno, D. (2019). Gambaran Kepatuhan Pemeriksaan PPIA (Pencegahan Penularan HIV dari Ibu Ke Anak) Ibu Hamil dengan Risiko HIV (Human Immunodeficiency Virus). Jaringan Laboratorium Medis, 1(1), 38–41. https://doi.org/10.31983/jlm.v1i1.5164.